GSK plc
GSK- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001131399
No open-market purchases or sales by GSK plc insiders were filed in the last 90 days; 1,048 institutions reported holding it in 13F filings for Q2 2026, worth $18.2B in total; no superinvestor holds it.
Other share classesGLAXF
Q2 2024 vs. Q1 2024
How the institutions holding GSK plc changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Of which not filed for Q2 2024 | Q2 2024 | Change |
|---|---|---|---|---|
| Holders | 911 | 14 | 887 | −10 |
| Shares | 311.1M | 100.2K | 312.2M | +1.20M (+0.4%) |
| Value | $13.3B | $4.26M | $12.0B | −$1.33B (−10.0%) |
14 institutions that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (78)
Institutions that held GSK plc at the end of Q2 2024 but not at the end of Q1 2024.
Sold out (88)
Institutions that held GSK plc at the end of Q1 2024 and filed for Q2 2024 without it.
Not filed for Q2 2024 yet (14)
Institutions that held GSK plc at the end of Q1 2024 and haven't filed a 13F for Q2 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| CWA Asset Management Group, LLC | 23,605 | $1.01M |
| Eudaimonia Advisors LLC | 16,499 | $707.3K |
| KLR Investment Advisors, LLC | 17,263 | $700.7K |
| Wilbanks Smith & Thomas Asset Management LLC | 13,950 | $598.0K |
| Grey Street Capital, LLC | 9,412 | $407.3K |
| InterOcean Capital Group, LLC | 8,579 | $367.8K |
| Credential Qtrade Securities Inc. | 8,369 | $358.8K |
| Highlander Capital Management, LLC | 852 | $36.5K |
| Norwood Financial Corp | 757 | $32.4K |
| Cambridge Trust Co | 308 | $13.2K |
| Cutler Group LP | 249 | $10.0K |
| FSA Wealth Management LLC | 146 | $6.27K |
| Pflug Koory, LLC | 140 | $6.00K |
| Retirement Group, LLC | 40 | $1.72K |